跳至主要内容
临床试验/NCT06442020
NCT06442020招募中不适用

Low Intensity Shock Wave Therapy in the Rehabilitation Treatment of Erectile Dysfunction After Robotic Radical Prostatectomy: Randomized Controlled Trial

Regina Elena Cancer Institute1 个研究点 分布在 1 个国家目标入组 158 人开始时间: 2023年9月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
158
试验地点
1
主要终点
Impact of LiESWT

研究概览

简要总结

The study deals with the hypothesis that LiESWT in addition to the administration of PDE5i can improve sexuality rehabilitation with faster recovery of a valid erection and higher IIEF-5 scores in the short and medium-term follow-up.

详细描述

Prospective randomized controlled trial (RCT) designed to provide high level evidences describing the role of Low-intensity Extracorporeal Shock Wave Therapy LiESWT plus early introduction of PDE5i vs early PDE5i alone on penile rehabilitation of erectile dysfunction ED after treatment of post-Robot-Assisted (RA) Radical Prostatectomy (RP) RARP

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Patients aged ≤75 yrs;
  • •Low-risk PCa (PSA <10 ng/mL and GS <7, ISUP grade 1, and cT1-2a) undergoing nerve sparing RARP;
  • •preoperative IIEF-5 score ≥ 17;
  • •First PSA (45d after surgery) <0.2
  • •compliants patients able to follow the study protocol and fill in IIEF-5 scores and EORTC quality of life questionnaires;
  • •patients able to provide a written informed consent for the trial.

排除标准

  • •anaesthesiologic contraindications to robotic surgery;
  • •patients submitted to pelvic radiotherapy or androgen deprivation;
  • •patients reporting major postoperative complications (CD≥3);
  • •cardiovascular contraindications to PDE5i medical treatment.

研究组 & 干预措施

GROUP 1: LiESWT in association with PDE5i

Experimental

Therapeutic association between low intensity extracorporeal shock waves LiESWT and the early introduction of the phosphodiesterase 5 inhibitor PDE5i

干预措施: Tadalafil (PDE5i) (Procedure)

GROUP 2: PDE5i alone

Active Comparator

Control group, administration of the phosphodiesterase 5 inhibitor PDE5i, as per clinical practice

干预措施: Tadalafil (PDE5i) (Procedure)

结局指标

主要结局

Impact of LiESWT

时间窗: 3 years

To evaluate the impact that the use of low intensity extracorporeal shock waves LiESWT in combination with the early administration of phosphodiesterase 5 inhibitors has on the patient in the process of penile rehabilitation in erectile dysfunction following post-assisted radical prostatectomy robot

次要结局

  • Assess how many patients reach orgasm(3 years)
  • Questionnaires of Quality of life(3 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验